<DOC>
	<DOCNO>NCT02728219</DOCNO>
	<brief_summary>The purpose study compare treatment recurrent hepatocellular carcinoma repeat hepatectomy , transcatheter arterial chemoembolization ( TACE ) AFP conversion .</brief_summary>
	<brief_title>Comparison Treatment Recurrent HCC With Repeat Hepatectomy , TACE With AFP Conversion</brief_title>
	<detailed_description>Though many HCC patient benefit hepatectomy treatment , still high recurrence rate hepatectomy lead limited effectiveness . This first study case system comparison effectiveness among repeat hepatectomy , TACE AFP conversion .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1. via clinical diagnosis confirm early recurrent liver cancer AFP conversion , accept anticancer treatment . 2. age:1870years 3. good liver function ( ChildPugh，class A B ) 1. reject attend； 2. impossible come hospital physical examination regularly . 3. cancer epitome、seed focus、lymph node distant metastasis 4 . Blood clot function hindrance ; 5. serious heart、lung、kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Recurrent Hepatocellular Carcinoma</keyword>
	<keyword>transcatheter arterial chemoembolization</keyword>
	<keyword>AFP conversion</keyword>
</DOC>